Lymphatic Disease: The Clinician/Patient Interface in State-of-the-Art Diagnosis and Management will be presented online in its entirety on Friday, September 30, 2022.
The diagnostic and therapeutic approaches to lymphatic diseases are rapidly evolving and becoming increasingly sophisticated. This long-awaited evolution has created an imperative for health care professionals to embrace these skills and the research support for their appropriate utilization. In parallel, it is imperative that health care professionals comprehend the profound impact of lymphatic disease and its treatment upon both function and quality-of-life. To this end, this year's state-of-the-art lymphatic medicine summit conference will both highlight state-of-the-art clinical management techniques and the patient user interface with both disease and its management. Evolving concepts and unanswered questions will be emphasized.
The Centers of Excellence Summit is hosted by Stanford University School of Medicine and LE&RN. It was organized and will be chaired by Stanley G. Rockson, M.D., the Allan and Tina Neill Professor of Lymphatic Research and Medicine at Stanford University.
The conference is considered appropriate for both health care professionals and patients and their families. Replays will be available after the conference until 11/01/22.
Upon completion of this activity, participants will be able to:
- Utilize the emerging diagnostic and therapeutic tools for the broad spectrum of lymphatic disease
- Appropriately address surgical and pharmacological decisions for lymphatic patients
- Utilize state-of-the-art diagnostic imaging to refine diagnostic evaluation
- Recommend state-of-the-art treatment options and interventions for patients with lymphatic disease, including those with lymphedema, lymphedema-related cellulitis, phlebolymphedema, lipedema, and lymphatic and complex vascular malformations
- Recognize and address the patient experience within these disease states and comprehend the patient experience during diagnosis and treatment
Up to 10 million Americans are estimated to be living with lymphedema (LE) and there are an additional 17 million women in America estimated to have lipedema (LI). The World Health Organization projects up to 250 million people with LE worldwide. Nevertheless, lymphatic patients still struggle to find physicians who are prepared to undertake their necessary medical care. Upon completion of this summit, participants will be better equipped to provide state-of-the-art lymphatic care.
Stanley G. Rockson, MD Summit Organizer Chief of Consultative Cardiology, Allan and Tina Neill Professor of Lymphatic Research and Medicine Professor of Medicine, Director, Center for Lymphatic and Venous Disorders Stanford University School of Medicine, Falk Cardiovascular Research Center
- Francine Blei, MD, MBA, Professor, NYU Grossman School of Medicine, NY
- Håkan Brorson, MD, PhD, Professor of Plastic Surgery, Department of Clinical Sciences, Lund University Malmö, Sweden
- Brett Carroll, MD, Assistant Professor of Medicine, Harvard Medical School, Director, Section of Vascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA
- Steven M. Dean, DO, FSVM PRVI, Clinical Professor of Internal Medicine, The Ohio State University Medical Center, Columbus, OH
- Jie Deng, PhD, RN, OCN, FAAN, Associate Professor of Nursing, University of Pennsylvania, Philadelphia, PA
- Sergio Gianesini, MD, PhD, FACS, University of Ferrara, Italy, Uniformed Services University of Health Sciences, Bethesda, MD
- Max Itkin, MD, Director, Penn Center for Lymphatic Disorders, Professor of Radiology at the Hospital of the University of Pennsylvania, Philadelphia, PA
- Stephen J. Kovach, MD, FACS, Herndon B. Lehr Endowed Associate Professor of Plastic Surgery, Associate Professor of Surgery, Division of Plastic Surgery, Associate Professor of Surgery, Department of Orthopaedic Surgery, Chief of Plastic Surgery, Penn Presbyterian Medical Center, Director, Microsurgery Fellowship, University of Pennsylvania Health System, Philadelphia, PA
- Fedor Lurie, MD, PhD, Jobst Vascular Institute and University of Michigan, Ann Arbor, MI
- Christine Moffatt, Lymphoedema Framework Project, UK
- Barbara A. Murphy, MD, Professor of Medicine, Division of Hematology Oncology, Director, Pain and Symptom Management Program, Director, Head and Neck Supportive Care Program, Vanderbilt University Medical Center, Nashville, TN
- Stanley G. Rockson, MD, Allan and Tinal Neill Professor of Lymphatic Research and Medicine, Stanford University,Palo Alto, CA
- Catherine Seo, PhD, Founder & CEO, Lipedema Simplified & Lipedema Project, Boston, MA
- Dhruv Singhal, The Lymphatic Center at Beth Israel Deaconess Medical Center, Boston, MA
- Andrzej Szuba, MD, PhD, Wroclaw Medical University, Poland
- Joyce M. C. Teng, MD, PhD, FAAD, Professor of Dermatology and Pediatrics, Director of Pediatric Dermatology and Fellowship Training, Stanford University School of Medicine, Palo Alto, CA
Stanley G. Rockson, Stanford University and LE&RN, Palo Alto, CA
William Repicci, President and CEO, LE&RN, New York, NY
If you are interested in another CME opportunity, click here.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning and LE&RN. ACHL is accredited by the ACCME to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Guidelines require that participants in CME activities be made aware of all financial relationships that may be perceived as affecting the presentation of the faculty member. ACHL ensures that all faculty and staff involved in the planning, development, and implementation of ACHL activities disclose financial relationships and that conflicts of interest are mitigated before the CME activity occurs. Complete information will be provided to participants prior to the start of the educational activity.